The Case of a Pregnant Woman with ARDS Due to COVID-19 Treated with Hydroxychloroquine, Azithromycin, and Remdesivir and Delivery of a Healthy Baby During Mechanical Ventilation Through Cesarean Section
The author(s) received no specific funding for this work.
We are in the midst of a pandemic due to SARS-CoV-2. Pregnancy was identified among the risk factors for worse clinical outcomes in multiple studies. The optimal therapy in this group of patients remains to be defined. Here, we present the case of a 39-year-old Caucasian pregnant female at 31 weeks of gestation, who was treated successfully with hydroxychloroquine, azithromycin, remdesivir, prone therapy, and cesarean delivery of a healthy baby while on mechanical ventilation. She remained SARS-CoV-2-positive until the 39th day of hospitalization. We discuss the pathophysiology of the increased risk of infections during pregnancy and particularly the high risk of microthombosis and coagulopathy due to COVID-19. Ultimately, the contribution of the medications used to the favorable outcomes remains unknown; it is more likely that the delivery helped to resolve the infection.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Madera-Acosta, Adria; Gnoni, Martin; Tappuni, Bassman; Sadlak, Monika; Grewal, Ravleen; Mena, Angel; and Ali-Ahwel, Yousef
"The Case of a Pregnant Woman with ARDS Due to COVID-19 Treated with Hydroxychloroquine, Azithromycin, and Remdesivir and Delivery of a Healthy Baby During Mechanical Ventilation Through Cesarean Section,"
The University of Louisville Journal of Respiratory Infections: Vol. 4
, Article 73.
Available at: https://ir.library.louisville.edu/jri/vol4/iss1/73